Physician profile
Jennifer Wheeler
NPI 1689988529
$934.32
in general payments reported to CMS, 2019-2025
10 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $22.68 · 2023: $23.08 · 2024: $330 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $334.38 | 2021-2025 | Evoque, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $145.10 | 2025 | Corevalve Evolut R |
| Abiomed | $141.63 | 2024 | Impella |
| Biotronik INC. | $108.99 | 2021 | |
| Stryker Corporation | $96.97 | 2024 | 1788 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.12 | 2023-2025 | Lifevest |
| Abbvie INC. | $22.68 | 2022 | |
| Ethicon US, LLC | $20.03 | 2024 | Surgicel Nu-Knit |
| Heartflow, INC. | $15.02 | 2023 | Ffrct |
| Atricure, INC. | $14.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.